§
Luxuse
Patent Intelligence
Sign In
← Back to Patent Explorer
US5202253A Expired / Lapsed US ⏱️ 0.0 years remaining

Monoclonal antibody specific for protein C and antibody purification method

Assignee: Oklahoma Medical Research Foundation
•
Filing: 1991-07-12
•
Granted: 1993-04-13
•
Expires: 2011-07-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A Ca2+ dependent monoclonal antibody that specifically binds to a specific twelve peptide sequence (E D Q V D P R L I D G K) in the activation region of the Protein C. The antibody does not bind to Activated Protein C and can be used to inhibit activation of Protein C by thrombin-thrombomodulin. The antibody can be isolated from cell culture or ascites fluid in large quantities by affinity chromatography with mild conditions using the peptide bound to an immobilized substrate. The antibody has a number of specific uses in isolation and characterization of Protein C and as a model for the design of Ca2+ dependent antibodies for the isolation of other proteins, as a diagnostic, and as a therapeutic to prevent activation of Protein C. The Protein C can be naturally produced or produced by expression of the recombinant gene. Advantages of the antibody in purification of Protein C include the specificity for Protein C and not Activated Protein C, and the unique Ca2+-peptide binding specificity which allows the binding site to be protected when it is being immobilized on the chromatographic support. In vivo, the antibody has been demonstrated to inhibit tumor growth. The antibody can also be used to promote clotting in patients having high levels of Factor VIII inhibitors.

Inventors

  • 👤 Charles T. Esmon
  • 👤 Naomi L. Esmon

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 10:13
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/6464; C07; C07K; C07K1/00; C07K1/107; C07K16/00; C07K16/40; C12Y; C12Y304/00; C12Y304/21; C12Y304/21069; A; A61; A61K; A61K38/00; G; G01; G01N; G01N2405/00; G01N2405/04

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 49 words
A calcium dependent monoclonal antibody specific for an epitope in the activation peptide region of the heavy chain of Protein C and calcium, produced by the hybridoma cell line HPC-4 deposited with the American Type Culture Collection, Rockville, Md., on Nov. 2, 1988, and assigned accession No. HB 9892.
Claim 2
Dependent Claim 49 words
A calcium dependent monoclonal antibody specific for an epitope in the activation peptide region of the heavy chain of Protein C and calcium, produced by the hybridoma cell line HPC-4 deposited with the American Type Culture Collection, Rockville, Md., on Nov. 2, 1988, and assigned accession No. HB 9892.
Claim 3
Dependent Claim 25 words
The antibody of claim 1 further comprising a label selected from the group consisting of radioactive molecules, chemiluminescent molecules, fluorescent molecules, luminescent molecules, and enzymes.
Claim 4
Dependent Claim 20 words
Hybridoma cell line HPC-4 deposited with the American Type Culture Collection Nov. 2, 1988 and assigned Accession No. HB 9892.
Claim 5
Dependent Claim 20 words
Hybridoma cell line HPC-4 deposited with the American Type Culture Collection Nov. 2, 1988 and assigned Accession No. HB 9892.
Claim 6
Independent Claim 133 words
A method for isolating a calcium-dependent monoclonal antibody specific for an epitope in the activation peptide region of the heavy chain of Protein C wherein said antibody has the variable region of monoclonal antibody HPC-4 deposited with the American Type Culture Collection, Rockville, Md. on Nov. 2, 1988 under the accession number HB 9892, comprising 1) providing an immobilized polypeptide not binding calcium and including the amino acid sequence: glutamic acid-aspartic acid-glutamine-valine-aspartic acid-proline-arginine-leucine-isoleucine-aspartic acid-glycine-lysine, or an immunologically equivalent sequence bound by HPC-4; 2) providing a solution containing the antibody to be separated and calcium, wherein the antibody binds the peptide in combination with the calcium; 3) incubating under conditions which allow binding of the antibody to the peptide to occur; and 4) eluting the antibody from the immobilized peptide by removing the calcium.
Claim 7
Independent Claim 133 words
A method for isolating a calcium-dependent monoclonal antibody specific for an epitope in the activation peptide region of the heavy chain of Protein C wherein said antibody has the variable region of monoclonal antibody HPC-4 deposited with the American Type Culture Collection, Rockville, Md. on Nov. 2, 1988 under the accession number HB 9892, comprising 1) providing an immobilized polypeptide not binding calcium and including the amino acid sequence: glutamic acid-aspartic acid-glutamine-valine-aspartic acid-proline-arginine-leucine-isoleucine-aspartic acid-glycine-lysine, or an immunologically equivalent sequence bound by HPC-4; 2) providing a solution containing the antibody to be separated and calcium, wherein the antibody binds the peptide in combination with the calcium; 3) incubating under conditions which allow binding of the antibody to the peptide to occur; and 4) eluting the antibody from the immobilized peptide by removing the calcium.
Claim 8
Dependent Claim 15 words
The method of claim 4 wherein the antibody is HPC-4 produced by hybridoma HB 98.

References Cited (Backward Citations)

US4506009A Cited
US5147638A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-04-12 1996-10-12 1997-04-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-04-12 2000-10-12 2001-04-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-04-12 2004-10-12 2005-04-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag